CUSIP 82024L103 · who reports it, how much, and how much it matters to them
15 of the 720 hedge fund managers we track reported shares of Shattuck Labs, Inc. (Nasdaq: STTK) on Form 13F for 30 June 2026. Between them they reported USD 206m. The largest position belongs to Adage Capital Management, at USD 56m. The manager with the most riding on it is Redmile Group, where it is 3.2% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Adage Capital Management1 fund on PPLI.com | USD 56m | 0.1% |
| 2 | Redmile Group10 funds on PPLI.com | USD 48m | 3.2% |
| 3 | Orbimed Advisors1 fund on PPLI.com | USD 44m | 0.8% |
| 4 | Deep Track Capital1 fund on PPLI.com | USD 26m | 0.4% |
| 5 | POINT72 Asset Management17 funds on PPLI.com | USD 8.1m | 0.0% |
| 6 | 683 Capital Management2 funds on PPLI.com | USD 8m | 0.4% |
| 7 | Boxer Capital Management1 fund on PPLI.com | USD 6.9m | 0.5% |
| 8 | Renaissance Technologies13 funds on PPLI.com | USD 5.2m | 0.0% |
| 9 | Millennium Management6 funds on PPLI.com | USD 1.3m | 0.0% |
| 10 | Two Sigma Investments35 funds on PPLI.com | USD 1.3m | 0.0% |
| 11 | Sphera Funds Management1 fund on PPLI.com | USD 600,000 | 0.1% |
| 12 | Squarepoint Ops7 funds on PPLI.com | USD 497,000 | 0.0% |
| 13 | Verdad Advisers6 funds on PPLI.com | USD 397,000 | 0.4% |
| 14 | Entrypoint Capital1 fund on PPLI.com | USD 183,000 | 0.0% |
| 15 | The Quarry1 fund on PPLI.com | USD 180 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Redmile Group | USD 48m | 3.2% |
| 2 | Orbimed Advisors | USD 44m | 0.8% |
| 3 | Boxer Capital Management | USD 6.9m | 0.5% |
| 4 | 683 Capital Management | USD 8m | 0.4% |
| 5 | Verdad Advisers | USD 397,000 | 0.4% |
| 6 | Deep Track Capital | USD 26m | 0.4% |
| 7 | Adage Capital Management | USD 56m | 0.1% |
| 8 | Sphera Funds Management | USD 600,000 | 0.1% |
| 9 | Entrypoint Capital | USD 183,000 | 0.0% |
| 10 | POINT72 Asset Management | USD 8.1m | 0.0% |
Shattuck Labs, Inc. trades under the symbol STTK on the Nasdaq. Its CUSIP, the code used on Form 13F, is 82024L103.
15 of the 720 hedge fund managers PPLI.com tracks reported Shattuck Labs, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Adage Capital Management (USD 56m), Redmile Group (USD 48m), Orbimed Advisors (USD 44m), Deep Track Capital (USD 26m) and POINT72 Asset Management (USD 8.1m).
15 managers in our coverage reported it, and between them they run 103 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Redmile Group, where the position was 3.2% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Shattuck Labs, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.